Page last updated: 2024-08-24

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Nasopharyngeal Carcinoma

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fan, CW; Jiang, JC; Li, MS; Tang, J; Wang, HS; Zhou, MM1

Other Studies

1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Nasopharyngeal Carcinoma

ArticleYear
Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Jul-20, Volume: 102

    Topics: Animals; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glycogen Synthase Kinase 3 beta; Humans; Hydrolyzable Tannins; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; p38 Mitogen-Activated Protein Kinases; TOR Serine-Threonine Kinases

2022